Active maternal cytomegalovirus (CMV) infection is the bedrock of congenital CMV with its debilitating sequelae. Information on socio-biologic predictors of active maternal infection in southwest Nigeria is lacking. However, modifying locality-specific risk factors could reduce the burden of CMV. The aim of the study is to identify the socio-biologic determinants for active maternal CMV infection in a Nigerian setting. Using a cross-sectional design, ELISA kits were employed to quantify the anti-CMV IgG and IgM antibodies in the sera of consecutive antenatal attendees at the Ekiti State University Teaching Hospital (EKSUTH), Nigeria. Among the respondents, 23 (12.4%) were seropositive for both anti-CMV IgG and IgM antibodies. The regression analysis showed that the likelihood of being seropositive for both anti-CMV IgG and IgM antibodies was predicted by having a child less than 5 years old (adjusted OR: 5.53; 95% CI: 1.08 – 28.30; p = 0.04), while those who were skilled workers were least likely to be seropositive for both antibodies (adjusted OR: 0.06; 95% CI: 0.01 – 0.95; p = 0.04). Also, infection with cytomegalovirus was associated with pre-eclampsia (adjusted OR: 0.03; 95% CI: 0.002 – 0.41; p = 0.01). High prevalence of active maternal CMV infection was noted from the study, and this was associated with pre-eclampsia and caring for children under-5. Educating pregnant non-immune women about CMV and its prevention, coupled with the improvement in socio-economic status of the populace can reduce the burden in low-resource settings.
Published in | Journal of Gynecology and Obstetrics (Volume 7, Issue 1) |
DOI | 10.11648/j.jgo.20190701.14 |
Page(s) | 25-30 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2019. Published by Science Publishing Group |
Cytomegalovirus, Socio-biologic Predictors, Immunoglobulin M (IgM), Screening, Low-resource Setting
[1] | S. Bonalumi, A. Trapanese, A. Santamaria, L. D’Emidio, and L. Mobili (2011). Cytomegalovirus infection in pregnancy: review of the literature. Journal of Perinatal Medicine 5, 1–8. |
[2] | J. G. Dobbins, J. A. Stewart, and G. J. Demmler (1992). Surveillance of congenital cytomegalovirus disease, 1990-1991. Collaborating Registry Group. MMWR CDC Surveill Summ 41, 35–39. |
[3] | M. J. Korndewal, A. M. Oudesluys-Murphy, A. C. M. Kroes, A. C. T. Vossen, and H. E. de Melker (2017). Congenital Cytomegalovirus Infection: Child Development, Quality of Life and Impact on Daily Life. Pediatr Infect Dis J 36, 1141–1147. |
[4] | A. Carlson, E. R. Norwitz, and R. J. Stiller (2010). Cytomegalovirus infection in pregnancy: Should all women be screened? Reviews in Obstetrics and Gynecology 3, 172–179. |
[5] | S. B. Boppana, L. B. Rivera, K. B. Fowler, M. Mach, and W. J. Britt (2001). Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 344, 1366–1371. |
[6] | A. Y. Yamamoto, M. M. Mussi-Pinhata, S. B. Boppana, Z. Novak, V. M. Wagatsuma, P. F. Oliveira, et al (2010). Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population. Am J Obstet Gynecol 202, 297.e1–8. |
[7] | R. F. Pass, and R. Arav-Boger (2018). Maternal and fetal cytomegalovirus infection: diagnosis, management, and prevention. F1000Research 7 (F1000 Faculty Rev), 255 (doi: 10.12688/f1000research.12517.1). |
[8] | S. M. Price, E. Bonilla, P. Zador, D. M. Levis, C. L. Kilgo, and M. J. Cannon (2014). Educating women about congenital cytomegalovirus: assessment of health education materials through a web-based survey. BMC Women’s Health 14, 144. DOI: 10.1186/S12905-014-0144-3. |
[9] | S. B. Boppana, R. F. Pass, W. J. Britt, S. Stagno, and C. A. Alford (1992). Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 11, 93–99. |
[10] | T. M. Lanzieri, S. C. Dollard, S. R. Bialek, and S. D. Grosse (2014). Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries. Int J Infect Dis 22, 44–48. |
[11] | Z. Mainji, and A. K. Nyamache (2014). Seroprevalence of Cytomegalovirus (CMV) among pregnant women in Thika, Kenya. BMC Res Notes 7, 794. |
[12] | A. Nawawy, A. T. Soliman, O. Azzouni, S. Amer, M. A. Karim, S. Demian, et al (1996). Maternal and neonatal prevalence of toxoplasma and cytomegalovirus (CMV) antibodies and hepatitis-B antigens in an Egyptian rural area. J Trop Pediatr 42, 154–157. |
[13] | S. I. Khairi, K. S. Intisar, K. H. Enan, M. Y. Ishag, A. M. Baraa, and Y. H. Ali (2013). Seroprevalence of cytomegalovirus infection among pregnant women at Omdurman Maternity Hospital. Sudan J Med Lab Diagn 4, 45–49. |
[14] | O. E. Ephraim, O. Oyinlola, V. L. Patrick, U. O. Joseph, and J. E. Charles (2013). Seroprevalence and risk factors for cytomegalovirus infection among pregnant women in southern Nigeria. JMID 3, 123–127. |
[15] | C. Bello, and H. Whittle (1991). Cytomegalovirus infection in Gambian mothers and their babies. J Clin Pathol 44, 366–369. |
[16] | K. B. Fowler, S. Stagno, R. F. Pass, W. J. Britt, T. J. Boll, and C. A. Alford (1992). The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 326, 663–667. |
[17] | C. Wang, X. Zhang, S. Bialek, and M. J. Cannon (2011). Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infections. Clin Infect Dis 52, e11–3. |
[18] | M. M. Mussi-Pinhata, A. Y. Yamamoto, R. M. Moura-Brito, I. M. de Lima, de Carvalhoe P. F. Oliveira, S. Boppana, et al (2009). Birth prevalence and natural history of congenital cytomegalovirus infection in a highly sero-immune population. Clin Infect Dis 49, 522–528. |
[19] | J. J. de Vries, E. W. van Zwet, F. W. Dekker, A. C. Kroes, P. H. Verkerk, and A. C. Vossen (2013). The apparent paradox of maternal seropositivity as a risk factor for congenital cytomegalovirus infection: a population-based prediction model. Rev Med Virol 23, 241–249. |
[20] | S. P. Adler, J. W. Finney, A. M. Manganello, and A. M. Best (2004). Prevention of child-to-mother transmission of cytomegalovirus among pregnant women. J Pediatr 145, 485–491. |
[21] | J. Harvey, and C. L. Dennis (2008). Hygiene interventions for prevention of cytomegalovirus infection among childbearing women: systematic review. J Adv Nurs 63, 440–450. |
[22] | C. Vauloup-Fellous, O. Picone, A. G. Cordier, I. Parent-du-Chatelet, M. N. Senat, R. Frydman, and L. Grangeot-Keros (2009). Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French Hospital. J Clin Virol 46, suppl 4: S49–53. |
[23] | R. F. Pass, and B. Anderson (2014). Mother-to-Child Transmission of Cytomegalovirus and Prevention of Congenital Infection. J Pediatric Infect Dis Soc 3, Suppl 1: S2–6. |
[24] | W. D. Rawlinson, S. B. Boppana, K. B. Fowler, D. W. Kimberlin, T. Lazzarotto, S. Alain, et al (2017). Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis 17, e177–e188. |
[25] | R. F. Pass, and C. Hutto (1986). Group day care and cytomegaloviral infections of mothers and children. Rev Infect Dis 8, 599–605. |
[26] | M. J. Cannon, J. D. Stowell, R. Clark, P. R. Dollard, D. Johnson, K. Mask, et al (2014). Repeated measures study of weekly and daily cytomegalovirus shedding patterns in saliva and urine of healthy cytomegalovirus-seropositive children. BMC Infect Dis 14, 569. |
[27] | S. A. S. Staras, S. C. Dollard, K. W. Radford, W. D. Flanders, R. F. Pass, and M. J. Cannon (2006). Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin Infect Dis 43, 1152–1153. |
[28] | S. P. Adler (1989). Cytomegalovirus and child day care. Evidence for an increased infection rate among day-care workers. N Engl J Med 321, 1290–1296. |
[29] | R. F. Pass, C. Hutto, M. D. Lyon, and G. Cloud (1990). Increased rate of cytomegalovirus infection among day care center workers. Pediatr Infect Dis J 9, 465–470. |
[30] | S. P. Adler (1988). Cytomegalovirus transmission among children in day care, their mothers and caretakers. Pediatr Infect Dis J 7, 279–285. |
[31] | R. F. Pass, C. Hutto, R. Ricks, and G. A. Cloud (1986). Increased rate of cytomegalovirus infection among parents of children attending day-care centers. N Engl J Med 314, 1414–1418. |
[32] | S. P. Adler, J. W. Finney, A. M. Manganello, and A. M. Best (2004). Prevention of child-to-mother transmission of cytomegalovirus among pregnant women. J Pediatr 145, 485–491. |
[33] | S. Stagno, R. F. Pass, G. Cloud, W. J. Britt, R. E. Henderson, P. D. Walton, et al (1986). Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA 256, 1904–1908. |
[34] | K. B. Fowler, S. Stagno, and R. F. Pass (2003). Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA 289, 1008–1011. |
[35] | P. D. Griffiths, and C. Baboonian (1984). Intra-uterine transmission of cytomegalovirus in women known to be immune before conception. J Hyg 92, 89–95. |
[36] | K. Schopfer, E. Lauber, and U. Krech (1978). Congenital cytomegalovirus infection in newborn infants of mothers infected before pregnancy. Arch Dis Child 53, 536–539. |
[37] | P. von Dadelszen, and L. A. Magee (2002). Could an infectious trigger explain the differential maternal response to the shared placental pathology of pre-eclampsia and normotensive intrauterine growth restriction? Acta Obstet Gynecol Scand 81, 642–648. |
[38] | D. G. Goulis, L. Chappell, R. G. Gibbs, D. Williams, J. R. Dave, P. Taylor, et al (2005). Association of raised titres of antibodies to Chlamydia pneumoniae with a history of pre-eclampsia. BJOG 112, 299–305. |
[39] | J. O. Awoleke, G. O. Ajayi, and O. Adegbola (2012). Prevalence of Chlamydophila pneumoniae antibodies in women with pre-eclampsia in Lagos, Nigeria. West African Journal of Medicine 31, 253–258. |
APA Style
Awoleke Jacob Olumuyiwa, Omoyajowo Adefunke Christianah, Ajayi David Daisi, Awoleke Adeola Olabisi. (2019). Socio-biologic Predictors of Active Cytomegalovirus Infection Among Pregnant Women in a Low-resource Setting. Journal of Gynecology and Obstetrics, 7(1), 25-30. https://doi.org/10.11648/j.jgo.20190701.14
ACS Style
Awoleke Jacob Olumuyiwa; Omoyajowo Adefunke Christianah; Ajayi David Daisi; Awoleke Adeola Olabisi. Socio-biologic Predictors of Active Cytomegalovirus Infection Among Pregnant Women in a Low-resource Setting. J. Gynecol. Obstet. 2019, 7(1), 25-30. doi: 10.11648/j.jgo.20190701.14
AMA Style
Awoleke Jacob Olumuyiwa, Omoyajowo Adefunke Christianah, Ajayi David Daisi, Awoleke Adeola Olabisi. Socio-biologic Predictors of Active Cytomegalovirus Infection Among Pregnant Women in a Low-resource Setting. J Gynecol Obstet. 2019;7(1):25-30. doi: 10.11648/j.jgo.20190701.14
@article{10.11648/j.jgo.20190701.14, author = {Awoleke Jacob Olumuyiwa and Omoyajowo Adefunke Christianah and Ajayi David Daisi and Awoleke Adeola Olabisi}, title = {Socio-biologic Predictors of Active Cytomegalovirus Infection Among Pregnant Women in a Low-resource Setting}, journal = {Journal of Gynecology and Obstetrics}, volume = {7}, number = {1}, pages = {25-30}, doi = {10.11648/j.jgo.20190701.14}, url = {https://doi.org/10.11648/j.jgo.20190701.14}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jgo.20190701.14}, abstract = {Active maternal cytomegalovirus (CMV) infection is the bedrock of congenital CMV with its debilitating sequelae. Information on socio-biologic predictors of active maternal infection in southwest Nigeria is lacking. However, modifying locality-specific risk factors could reduce the burden of CMV. The aim of the study is to identify the socio-biologic determinants for active maternal CMV infection in a Nigerian setting. Using a cross-sectional design, ELISA kits were employed to quantify the anti-CMV IgG and IgM antibodies in the sera of consecutive antenatal attendees at the Ekiti State University Teaching Hospital (EKSUTH), Nigeria. Among the respondents, 23 (12.4%) were seropositive for both anti-CMV IgG and IgM antibodies. The regression analysis showed that the likelihood of being seropositive for both anti-CMV IgG and IgM antibodies was predicted by having a child less than 5 years old (adjusted OR: 5.53; 95% CI: 1.08 – 28.30; p = 0.04), while those who were skilled workers were least likely to be seropositive for both antibodies (adjusted OR: 0.06; 95% CI: 0.01 – 0.95; p = 0.04). Also, infection with cytomegalovirus was associated with pre-eclampsia (adjusted OR: 0.03; 95% CI: 0.002 – 0.41; p = 0.01). High prevalence of active maternal CMV infection was noted from the study, and this was associated with pre-eclampsia and caring for children under-5. Educating pregnant non-immune women about CMV and its prevention, coupled with the improvement in socio-economic status of the populace can reduce the burden in low-resource settings.}, year = {2019} }
TY - JOUR T1 - Socio-biologic Predictors of Active Cytomegalovirus Infection Among Pregnant Women in a Low-resource Setting AU - Awoleke Jacob Olumuyiwa AU - Omoyajowo Adefunke Christianah AU - Ajayi David Daisi AU - Awoleke Adeola Olabisi Y1 - 2019/04/13 PY - 2019 N1 - https://doi.org/10.11648/j.jgo.20190701.14 DO - 10.11648/j.jgo.20190701.14 T2 - Journal of Gynecology and Obstetrics JF - Journal of Gynecology and Obstetrics JO - Journal of Gynecology and Obstetrics SP - 25 EP - 30 PB - Science Publishing Group SN - 2376-7820 UR - https://doi.org/10.11648/j.jgo.20190701.14 AB - Active maternal cytomegalovirus (CMV) infection is the bedrock of congenital CMV with its debilitating sequelae. Information on socio-biologic predictors of active maternal infection in southwest Nigeria is lacking. However, modifying locality-specific risk factors could reduce the burden of CMV. The aim of the study is to identify the socio-biologic determinants for active maternal CMV infection in a Nigerian setting. Using a cross-sectional design, ELISA kits were employed to quantify the anti-CMV IgG and IgM antibodies in the sera of consecutive antenatal attendees at the Ekiti State University Teaching Hospital (EKSUTH), Nigeria. Among the respondents, 23 (12.4%) were seropositive for both anti-CMV IgG and IgM antibodies. The regression analysis showed that the likelihood of being seropositive for both anti-CMV IgG and IgM antibodies was predicted by having a child less than 5 years old (adjusted OR: 5.53; 95% CI: 1.08 – 28.30; p = 0.04), while those who were skilled workers were least likely to be seropositive for both antibodies (adjusted OR: 0.06; 95% CI: 0.01 – 0.95; p = 0.04). Also, infection with cytomegalovirus was associated with pre-eclampsia (adjusted OR: 0.03; 95% CI: 0.002 – 0.41; p = 0.01). High prevalence of active maternal CMV infection was noted from the study, and this was associated with pre-eclampsia and caring for children under-5. Educating pregnant non-immune women about CMV and its prevention, coupled with the improvement in socio-economic status of the populace can reduce the burden in low-resource settings. VL - 7 IS - 1 ER -